Endothelial Insulin Receptors Promote VEGF-A Signaling via ERK1/2 and Sprouting Angiogenesis
Year: 2021
Type: article
Abstract: Endothelial insulin receptors (Insr) promote sprouting angiogenesis, although the underpinning cellular and molecular mechanisms are unknown. Comparing mice with whole-body insulin receptor haploinsufficiency (Insr+/-) against littermate controls, we found impaired limb perfusion and muscle capillary density after inducing hind-limb ischemia; this was in spite of increased expression of the proangiogenic growth factor Vegfa. Insr+/- neonatal retinas exhibited reduced tip cell number and branching complexity during developmental angiogenesis, which was also found in separate studies of mice with endothelium-restricted Insr haploinsufficiency. Functional responses to vascular endothelial growth factor A (VEGF-A), including in vitro angiogenesis, were also impaired in aortic rings and pulmonary endothelial cells from Insr+/- mice. Human umbilical vein endothelial cells with shRNA-mediated knockdown of Insr also demonstrated impaired functional angiogenic responses to VEGF-A. VEGF-A signaling to Akt and endothelial nitric oxide synthase was intact, but downstream signaling to extracellular signal-reduced kinase 1/2 (ERK1/2) was impaired, as was VEGF receptor-2 (VEGFR-2) internalization, which is required specifically for signaling to ERK1/2. Hence, endothelial insulin receptors facilitate the functional response to VEGF-A during angiogenic sprouting and are required for appropriate signal transduction from VEGFR-2 to ERK1/2.
Source: Endocrinology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
Awards: Examining the effect of increasing endothelial cell insulin like growth factor-1 receptor expression in the endothelium on blood pressure homeostasis and endothelial cell function in health and diet induced type 2 diabetes mellitus (Dr Thomas Slater), Manipulating insulin like growth factor-1 and hybrid receptor expression as a therapeutic strategy to control insulin sensitivity and cardiovascular repair (renewal), Endothelial cell insulin sensitivity, nitric oxide bioavailability and atherosclerosis, Manipulating the phenotype of endothelial progenitor cells from insulin resistant South Asian men: towards cell based therapies, G3328523236, Examining the effect of reducing IGF-1 receptor expression in late outgrowth endothelial progenitor cells from insulin resistant humans, Does cellular insulin signalling modulate endogenous vascular repair and endothelial progenitor cell function via interaction with VEGF signalling?, Dissecting the role of endothelial insulin-like growth factor-1 signalling in the vascular and metabolic complications of obesity-induced type 2 diabetes mellitus, Targeting Nox2 NADPH oxidase in insulin resistance related atherosclerosis and oxidative stress, G7113225679, The BHF Chair of Cardiovascular and Diabetes Research
OpenAlex ID: W3165532735
